Adaptimmune Therapeutics Plc (ADAP) Insider Trading
- $80,274,368.40
- $25,022,068.20
- Jan. 31, 2023
- Adrian Rawcliffe
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 31, 2023 | Insider | 11,890 | $1.87 | Sell | $22,234.30 | |
Jan. 17, 2023 | CEO | 10,057 | $1.86 | Sell | $18,706.02 | |
Jan. 17, 2023 | Insider | 4,440 | $1.86 | Sell | $8,258.40 | |
Jan. 12, 2023 | COO | 4,973 | $1.71 | Sell | $8,503.83 | |
Jan. 12, 2023 | CEO | 18,763 | $1.71 | Sell | $32,084.73 | |
Jan. 11, 2023 | Insider | 3,843 | $1.75 | Sell | $6,725.25 | |
Jan. 4, 2023 | CEO | 5,073 | $1.69 | Sell | $8,573.37 | |
Jan. 4, 2023 | COO | 3,584 | $1.69 | Sell | $6,056.96 | |
Jan. 4, 2023 | Insider | 1,100 | $1.69 | Sell | $1,859.00 | |
Sept. 1, 2022 | CEO | 2,536 | $1.97 | Sell | $4,995.92 | |
Aug. 1, 2022 | Insider | 2,983 | $1.77 | Sell | $5,279.91 | |
July 5, 2022 | Insider | 1,973 | $1.68 | Sell | $3,314.64 | |
June 27, 2022 | CEO | 2,562 | $1.63 | Sell | $4,176.06 | |
May 20, 2022 | CFO | 39,000 | $0.29 | Buy | $11,310.00 | |
Jan. 18, 2022 | COO | 4,368 | $3.19 | Sell | $13,933.92 | |
Jan. 18, 2022 | CEO | 11,096 | $3.19 | Sell | $35,396.24 | |
Jan. 18, 2022 | Insider | 2,121 | $3.19 | Sell | $6,765.99 | |
Jan. 12, 2022 | Insider | 1,076 | $3.54 | Sell | $3,809.04 | |
Jan. 11, 2022 | CEO | 14,362 | $3.56 | Sell | $51,128.72 | |
Jan. 11, 2022 | COO | 3,770 | $3.56 | Sell | $13,421.20 | |
Jan. 4, 2022 | COO | 3,490 | $4.06 | Sell | $14,169.40 | |
Jan. 4, 2022 | CEO | 5,532 | $4.06 | Sell | $22,459.92 | |
Jan. 4, 2022 | Insider | 1,070 | $4.06 | Sell | $4,344.20 | |
Sept. 1, 2021 | CEO | 2,782 | $5.20 | Sell | $14,466.40 | |
Aug. 2, 2021 | Insider | 2,939 | $3.58 | Sell | $10,521.62 | |
June 28, 2021 | CEO | 2,794 | $4.37 | Sell | $12,209.78 | |
Jan. 19, 2021 | Insider | 2,111 | $5.67 | Sell | $11,969.37 | |
Jan. 19, 2021 | CEO | 9,879 | $5.67 | Sell | $56,013.93 | |
Jan. 12, 2021 | Insider | 1,058 | $6.15 | Sell | $6,506.70 | |
Jan. 12, 2021 | CEO | 2,707 | $6.15 | Sell | $16,648.05 | |
Jan. 12, 2021 | COO | 2,234 | $6.15 | Sell | $13,739.10 | |
Jan. 4, 2021 | CEO | 4,967 | $5.33 | Sell | $26,474.11 | |
Jan. 4, 2021 | Insider | 1,065 | $5.33 | Sell | $5,676.45 | |
Jan. 4, 2021 | COO | 3,499 | $5.33 | Sell | $18,649.67 | |
Dec. 14, 2020 | CFO | 24,000 | $0.69 | Buy | $16,560.00 | |
Dec. 14, 2020 | COO | 207,000 | $0.69 | Buy | $142,830.00 | |
Sept. 1, 2020 | CEO | 2,776 | $8.51 | Sell | $23,623.76 | |
Aug. 3, 2020 | Insider | 4,823 | $9.25 | Sell | $44,612.75 | |
Aug. 3, 2020 | CEO | 2,788 | $9.25 | Sell | $25,789.00 | |
June 29, 2020 | CFO | 33,000 | $1.62 | Buy | $53,460.00 | |
June 9, 2020 | Director | 12,900 | $1.89 | Buy | $24,381.00 | |
May 29, 2020 | Director | 500,000 | $9.33 | Sell | $4,665,000.00 | |
Jan. 24, 2020 | Major Shareholder | 7,500,000 | $0.67 | Buy | $5,025,000.00 | |
Jan. 14, 2020 | CEO | 3,236 | $5.13 | Sell | $16,600.68 | |
Jan. 14, 2020 | Insider | 911 | $5.13 | Sell | $4,673.43 | |
Jan. 14, 2020 | COO | 2,397 | $5.13 | Sell | $12,296.61 | |
Jan. 13, 2020 | Director | 300,000 | $4.67 | Sell | $1,401,000.00 | |
Jan. 6, 2020 | COO | 3,731 | $1.20 | Sell | $4,477.20 | |
Jan. 6, 2020 | CEO | 5,900 | $1.20 | Sell | $7,080.00 | |
Jan. 6, 2020 | Insider | 1,148 | $1.20 | Sell | $1,377.60 |
Insiders are both buying and selling Adaptimmune Therapeutics Plc stock.
The insider traders at Adaptimmune Therapeutics Plc are: Adrian Rawcliffe, John Lunger, William C. Bertrand, Jr., Orbimed Advisors Llc, William C Bertrand Jr, Enterprise Associates 14 New, Elliot Norry, Peter A Thompson, Gavin Wood, Gwendolyn Knowlt Binder-Scholl, David M Mott, James Noble, Charles Elliott Sigal, Lawrence M. Alleva, Rafael Amado, Ali Behbahani, Peter W Sonsini, Ravi Viswanathan, and Cintia Piccina
The most active insider trader at Adaptimmune Therapeutics Plc is Adrian Rawcliffe with 19 trades.
Orbimed Advisors Llc has sold the most Adaptimmune Therapeutics Plc stock with a total value of $14,870,124.50.
Ali Behbahani has bought the most Adaptimmune Therapeutics Plc stock with a total value of $40,080,000.00.
The most recent insider trade for Adaptimmune Therapeutics Plc was on Jan. 31, 2023.
The single biggest insider buy for Adaptimmune Therapeutics Plc was from Ali Behbahani with a total value of $20,040,000.00 on Sept. 7, 2018.
The single biggest insider sell for Adaptimmune Therapeutics Plc was from Orbimed Advisors Llc with a total value of $12,052,770.50 on March 29, 2018.